Solid Biosciences SLDB
NASDAQ SLDB
$10.25 -0.17 (-1.63%)
At close: Sep 4, 2026 · 4:00 PM EDT

Solid Biosciences (SLDB) Prepaid Assets (2017 - 2026)

Solid Biosciences (SLDB) posted Prepaid Assets of $15.5 million for Q1 2026, down 5.58% sequentially from $16.4 million in Q4 2025, and up 138.33% YoY from $6.5 million in Q1 2025.

Analysis

Solid Biosciences (SLDB) Prepaid Assets (2017 - 2026) Analysis & Trends

Solid Biosciences has reported Prepaid Assets for 10 years, with the latest figure at $15.5 million in Q1 2026.

  • Quarterly Prepaid Assets rose 138.33% year-over-year to $15.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.5 million (up 138.33% YoY) and the FY2025 annual result came in at $16.4 million, up 95.47% from the prior year.
  • Prepaid Assets slipped to $15.5 million in Q1 2026 per SLDB's latest filing, from $16.4 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $18.5 million in Q1 2022 and troughed at $5.1 million in Q1 2023.
  • A 5-year average of $8.9 million and a median of $7.3 million in 2024 frame the typical range for Prepaid Assets.
  • The sharpest annual moves came in 2022 and 2023: Prepaid Assets soared 236.06% in 2022, then slumped 72.52% in 2023.
  • Over 5 years, Prepaid Assets stood at $5.9 million in 2022, then gained by 3.01% to $6.1 million in 2023, then soared by 37.55% to $8.4 million in 2024, then surged by 95.47% to $16.4 million in 2025, then fell by 5.58% to $15.5 million in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $15.5 million, $16.4 million, and $8.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Solid Biosciences 1.48 Bn 1.48 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.79 Mn
Mar 31, 2026 15.47 Mn
Dec 31, 2025 16.38 Mn
Sep 30, 2025 8.71 Mn
Jun 30, 2025 10.53 Mn
Mar 31, 2025 6.49 Mn
Dec 31, 2024 8.38 Mn
Sep 30, 2024 8.38 Mn
Jun 30, 2024 7.34 Mn
Mar 31, 2024 8.13 Mn
Dec 31, 2023 6.09 Mn
Sep 30, 2023 5.46 Mn
Jun 30, 2023 7.28 Mn
Mar 31, 2023 5.10 Mn
Dec 31, 2022 5.92 Mn
Sep 30, 2022 5.12 Mn
Jun 30, 2022 7.32 Mn
Mar 31, 2022 18.54 Mn
Dec 31, 2021 14.72 Mn
Sep 30, 2021 8.37 Mn